Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Retifanlimab + Bevacizumab + Radiation for Recurrent Glioblastoma
Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial tests if retifanlimab + bevacizumab + radiation can improve treatment of recurrent glioblastoma. Protein and drugs may help immune system fight cancer & stop blood vessels supplying tumor.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service